NASDAQ

Palisade Bio, Inc. (PALI)

♥ 1049 Thanks from members

Live price chart, market sentiment, and community perspectives for Palisade Bio, Inc. (NASDAQ: PALI).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Palisade Bio FoundersLeadership: J. David Clark (CEO)Leadership: Tom Hallam (CFO)Holder: Institutional Healthcare FundsHolder: Private Equity InvestorsLB1148 Oral LiquidGastrointestinal TherapeuticsProtease Inhibitor Pipeline#PALI stock#Palisade Bio#biopharmaceutical development#NASDAQ PALI#GI disease therapeutics